Topic Biosimilars
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biosimilars vs. Originators: A Comprehensive Guide for Nurses on Efficacy, Safety, and Patient Care
Price: $21.95Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: N1224BPublished: Dec 2024Expires: 12/4/2026Sources: Nursing 2025Details -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} CRNI® Recertification Units & CE Credit - Infusion Topics: Hemochromatosis; Care of Substance Users; Hyperemesis Gravidarum; Cancer Patients' CVCs; Biosimilar Basics
Price: $200.00Credits:
- ANCC 5.0 CH
- INCC 10.0 CRNI
- DC - BON 5.0 CH
- FL - BON 5.0 CH
- GA - BON 5.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JINNR0320Published: March 2020Expires: 3/7/2025Sources: Journal of Infusion NursingDetailsRequired Passing Score: 65/82 (79%)Specialties: Acute Care, Advanced Practice Nursing, Ambulatory Care, Critical Care, Infusion, PerinatalTopics: Biosimilars , Hemochromatosis , Hyperemesis Gravidarum , Infusion , Infusion Nurses Society (INS) , Substance Use DisordersMedia: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} CE Credit - Infusion Topics: Hemochromatosis; Care of Substance Users; Hyperemesis Gravidarum; Cancer Patients' CVCs; Biosimilar Basics
Price: $42.50Credits:
- ANCC 5.0 CH
- DC - BON 5.0 CH
- FL - BON 5.0 CH
- GA - BON 5.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JINNC0320Published: March 2020Expires: 3/7/2025Sources: Journal of Infusion NursingDetailsRequired Passing Score: 65/82 (79%)Specialties: Acute Care, Advanced Practice Nursing, Ambulatory Care, Critical Care, Infusion, PerinatalTopics: Biosimilars , Hemochromatosis , Hyperemesis Gravidarum , Infusion , Infusion Nurses Society (INS) , Substance Use DisordersMedia: